Ng AK, Travis LB. Subsequent malignant neoplasms in cancer survivors. Cancer J (Sudbury, Mass). 2008;14(6):429–34.
Travis LB. The epidemiology of second primary cancers. Cancer Epidemiol Biomark Prev. 2006;15(11):2020–6.
Youlden DR, Baade PD. The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study. BMC cancer. 2011;11(1):83.
Article PubMed PubMed Central Google Scholar
Matthews NH, Li W-Q, Qureshi AA, Weinstock MA, Cho E. Epidemiology of melanoma. In: Ward WH, Farma JM, editors. Cutaneous melanoma: etiology and therapy. Brisbane (AU): Codon Publications; 2017.
Watts CG, McLoughlin K, Goumas C, Van Kemenade CH, Aitken JF, Soyer HP, et al. Association between melanoma detected during routine skin checks and mortality. JAMA Dermatol. 2021;157(12):1425.
Yue X, Pengfei XuP. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14(10):101174.
Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338–44.
Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Gastroenterol Rev. 2019;14(2):89–103.
Araghi M, Arnold M, Rutherford MJ, Guren MG, Cabasag CJ, Bardot A, et al. Colon and rectal cancer survival in seven high-income countries 2010–2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut. 2021;70(1):114–26.
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA: A Cancer J Clin. 2016;66(4):271–89.
Caini S, Boniol M, Botteri E, Tosti G, Bazolli B, Russell-Edu W, et al. The risk of developing a second primary cancer in melanoma patients: a comprehensive review of the literature and meta-analysis. J Dermatol Sci. 2014;75(1):3–9.
Caini S, Radice D, Tosti G, Spadola G, Cocorocchio E, Ferrucci PF, et al. Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy. J Eur Acad Dermatol Venereol. 2016;30(9):1491–6.
Article CAS PubMed Google Scholar
Zheng G, Chattopadhyay S, Sundquist K, Sundquist J, Försti A, Hemminki A, Hemminki K. Association between tumor characteristics and second primary cancers with cutaneous melanoma survival: a nationwide cohort study. Pigment Cell Melanoma Res. 2020;33(4):625–32.
Article CAS PubMed Google Scholar
Levi F, Randimbison L, Te V-C, Conconi MM, La Vecchia C. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis. Int J Cancer. 2008;123(12):2899–901.
Article CAS PubMed Google Scholar
Hemminki K, Li X, Dong C. Second primary cancers after sporadic and familial colorectal cancer. Cancer Epidemiol Biomarkers Prev : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2001;10(7):793–8.
Dasgupta P, Youlden DR, Baade PD. Multiple primary cancers among colorectal cancer survivors in Queensland, Australia, 1996–2007. Cancer Causes Control. 2012;23(8):1387–98.
Ye Y, Otahal P, Wills KE, Neil AL, Venn AJ. Temporal trends in the risk of second primary cancers among survivors of adult-onset cancers, 1980 through 2013: asn Australian population-based study. Cancer. 2018;124(8):1808–18.
Halamkova J, Kazda T, Pehalova L, Gonec R, Kozakova S, Bohovicova L, et al. Second primary malignancies in colorectal cancer patients. Sci Rep. 2021;11(1):2759.
Article CAS PubMed PubMed Central Google Scholar
He X, Wu W, Ding Ye, Li Y, Si J, Sun L. Excessive risk of second primary cancers in young‐onset colorectal cancer survivors. Cancer Med (Malden, MA). 2018;7(4):1201–10.
Jia H, Li Q, Yuan J, Sun X, Wu Z. Second primary malignancies in patients with colorectal cancer: a population-based analysis. Oncol (Dayton, Ohio). 2020;25(4):e644–50.
Robertson D, Ng SK, Baade PD, Lam AK. Risk of extracolonic second primary cancers following a primary colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2022;37(3):541–51.
Article PubMed PubMed Central Google Scholar
Levi F, Randimbison L, La Vecchia C, Te VC, Franceschi S. Cancer risk following polyps or cancer of the large bowel in Vaud. Switzerland Int J Cancer. 1999;80(4):634–5.
Article CAS PubMed Google Scholar
Enblad P, Adami H-O, Glimelius B, Krusemo U, Pahlman L. The risk of subsequent primary malignant diseases after cancers of the colon and rectum a nationwide cohort study. Cancer. 1990;65(9):2091–100.
Article CAS PubMed Google Scholar
Lee Y-T, Liu C-J, Hu Y-W, Teng C-J, Tzeng C-H, Yeh C-M, et al. Incidence of second primary malignancies following colorectal cancer: a distinct pattern of occurrence between colon and rectal cancers and association of co-morbidity with second primary malignancies in a population-based cohort of 98,876 patients in Taiwan. Medicine. 2015;94(26):e1079.
Article PubMed PubMed Central Google Scholar
Bright CJ, Reulen RC, Winter DL, Stark DP, McCabe MG, Edgar AB, et al. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study. Lancet Oncol. 2019;20(4):531–45.
Article PubMed PubMed Central Google Scholar
Crocetti E, Carli P. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients. Eur J Cancer Prev. 2004;13(1):33–7.
Article CAS PubMed Google Scholar
Wassberg C, Thörn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer. 1996;73(2):255–9.
Article CAS PubMed PubMed Central Google Scholar
Jung GW, Dover DC, Salopek TG. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009. Br J Dermatol (1951). 2014;170(1):136–43.
Hwang C-Y, Chen Y-J, Lin M-W, Chen T-J, Chu S-Y, Chen C-C, et al. Elevated risk of second primary cancer in patients with cutaneous malignant melanoma: a nationwide cohort study in Taiwan. J Dermatol Sci. 2010;60(3):167–72.
Schmid-Wendtner MH, Baumert J, Wendtner CM, Plewig G, Volkenandt M. Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol (1951). 2001;145(6):981–5.
Robsahm TE, Karagas MR, Rees JR, Syse A. New malignancies after squamous cell carcinoma and melanomas: a population-based study from Norway. BMC cancer. 2014;14(1):210.
Article PubMed PubMed Central Google Scholar
Kimlin MG, Youlden DR, Brodie AM, DiSipio T, Youl P, Nair-Shalliker V, Baade PD. Risk of second primary cancer in survivors of in situ melanoma. J Investig Dermatol. 2019;139(4):842–7.
Article CAS PubMed Google Scholar
Deng W, Wang Y, Liu X, Liu J, Wang L, Yang Z, et al. Assessment of trends in second primary cancers in patients with metastatic melanoma from 2005 to 2016. JAMA network open U6 - ctx_ver=Z3988–2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummonserialssolutionscom&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rftgenre=article&rftatitle=Assessment+of+Trends+in+Second+Primary+Cancers+in+Patients+With+Metastatic+Melanoma+From+2005+to+2016&rftjtitle=JAMA+network+open&rftdate=2020–12–01&rfteissn=2574–3805&rftvolume=3&rftissue=12&rftspage=e2028627&rftepage=e2028627&rft_id=info:doi/101001%2Fjamanetworkopen202028627&rftexternalDBID=NO_FULL_TEXT¶mdict=en-US U7 - Journal Article. 2020;3(12):e2028627-e.
Luu Y, Han J, Agarwal A, Elkady N, Jaroonwanichkul S, Gulati N, Gittler J. Risk for second primary cancers among pediatric and young adult melanoma survivors. Pediatr Dermatol. 2023;41(1):12–5.
Spanogle JP, Clarke CA, Aroner S, Swetter SMVAPAHCSPAC. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. J Am Acad Dermatol. 2010;62(5):757–67.
American Academy of Dermatology Association. Melanoma strikes men harder 2017 [Available from: https://www.aad.org/public/diseases/skin-cancer/types/common/melanoma/men-50.
Bellenghi M, Puglisi R, Pontecorvi G, Feo AD, Carè A, Mattia G. Sex and gender disparities in melanoma. Cancers. 1819;2020(12):1819.
Comments (0)